20 Nov 2026, 09:56
Company Update—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Nov 2026, 09:56 | Mesoblast Wins Deloitte Tech Fast 50 Leadership Award | Company Update | — | 11001 | |
| 16 Nov 2026, 09:48 | Mesoblast Showcased at ASX Investor Day | Company Administration | — | 12008 | |
| 16 Nov 2026, 09:42 | CEO Presentation ASX Investor Day | Presentations | — | 03026 | |
| 13 Nov 2026, 17:06 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 10 Nov 2026, 17:14 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 10 Nov 2026, 09:07 | CEO Presentation to 2026 Annual General Meeting | Presentations | — | 03026, 15002 | |
| 10 Nov 2026, 08:59 | Mesoblast Chair Message to 2026 AGM | Letters & Addresses | — | 15002 | |
| 10 Nov 2026, 08:55 | Expands Management to Drive Blockbuster Potential of Rex-L | Company Update | — | 11001 | |
| 10 Nov 2026, 08:47 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 10 Nov 2026, 08:46 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 5 Nov 2026, 09:58 | Use of Ryoncil Highlighted in Key Opinion Leader Webinar | Company Update | — | 11001, 14014 | |
| 2 Nov 2026, 10:01 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 2 Nov 2026, 09:59 | Mesoblast Board Changes | Company Administration | — | 12001, 12008 | |
| 29 Oct 2026, 09:54 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 27 Oct 2026, 18:52 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 26 Oct 2026, 19:24 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 22 Oct 2026, 19:20 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 16 Oct 2026, 10:15 | MSB Reports Increased Revenue and Improved Operating Spend | Periodic Reports | MS | 03014 | |
| 14 Oct 2026, 17:10 | Notification of cessation of securities - MSB | Securities Administration | — | 06027 | |
| 14 Oct 2026, 17:07 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 14 Oct 2026, 17:03 | Application for quotation of securities - MSB | Securities Administration | — | 06020 | |
| 12 Oct 2026, 16:23 | Annual Report to Shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013 | |
| 12 Oct 2026, 16:13 | Notice of Annual General Meeting and Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 12 Oct 2026, 16:05 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 1 Oct 2026, 18:49 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 30 Sept 2026, 18:15 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 24 Sept 2026, 09:52 | FDA Approves New Potency Assay for Commercial Ryoncil | Company Update | MS | 11001 | |
| 23 Sept 2026, 18:41 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 27 Aug 2026, 08:39 | MSB Annual Financial Results and Operational Update | Financial Results | MS | 03003, 14014 | |
| 27 Aug 2026, 08:33 | Annual Financial Results Presentation | Financial Results | MS | 03003, 03026 | |
| 27 Aug 2026, 08:21 | Preliminary Final Report including Appendix 4E | Financial Results | MS | 03003, 03011, 03012, 03013 | |
| 24 Aug 2026, 17:50 | Appendix 3Y - Philip Krause | Director Interests | — | 02009 | |
| 24 Aug 2026, 17:40 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 24 Aug 2026, 17:38 | Mesoblast 2026 Full Year Financial Results Webcast | Presentations | — | 14014 | |
| 17 Aug 2026, 10:00 | Major Milestone Treatment Completed in P3 Trial for CLBP | Company Update | MS | 11001 | |
| 13 Aug 2026, 17:52 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 7 Aug 2026, 17:02 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 5 Aug 2026, 18:29 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 3 Aug 2026, 17:25 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 31 July 2026, 17:06 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 30 July 2026, 10:01 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 24 July 2026, 17:00 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 22 July 2026, 08:23 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 21 July 2026, 09:53 | Mesoblast CEO Makes Investment to Increase Share Ownership | Substantial Holders | — | 02006, 06009 | |
| 21 July 2026, 09:47 | Appendix 3Y - Silviu Itescu | Director Interests | — | 02009 | |
| 21 July 2026, 09:43 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 21 July 2026, 09:33 | Application for quotation of securities - MSB | Securities Administration | — | 06020 | |
| 14 July 2026, 17:31 | Notification of cessation of securities - MSB | Securities Administration | — | 06027 | |
| 14 July 2026, 17:25 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 14 July 2026, 17:21 | Application for quotation of securities - MSB | Securities Administration | — | 06020 |